Risk of cancer therapy-related cardiotoxicity following the use of PD-1/PD-L1 inhibitors combined with chemoradiotherapy compared with chemoradiotherapy in solid tumors: a systematic review and Meta-analysis
Review|更新时间:2026-02-09
|
Risk of cancer therapy-related cardiotoxicity following the use of PD-1/PD-L1 inhibitors combined with chemoradiotherapy compared with chemoradiotherapy in solid tumors: a systematic review and Meta-analysis
“The latest research focuses on the field of tumor treatment, and experts have found through meta-analysis that the combination of PD-1/PD-L1 inhibitors with radiotherapy and chemotherapy increases the risk of cardiac toxicity, especially in terms of heart failure and arrhythmia, providing important references for the safety evaluation of tumor treatment.”
China OncologyVol. 35, Issue 12, Pages: 1126-1139(2025)
ZHENG Jinmei, WU Wanghui, ZHENG Jimei, et al. Risk of cancer therapy-related cardiotoxicity following the use of PD-1/PD-L1 inhibitors combined with chemoradiotherapy compared with chemoradiotherapy in solid tumors: a systematic review and Meta-analysis[J]. China Oncology, 2025, 35(12): 1126-1139.
DOI:
ZHENG Jinmei, WU Wanghui, ZHENG Jimei, et al. Risk of cancer therapy-related cardiotoxicity following the use of PD-1/PD-L1 inhibitors combined with chemoradiotherapy compared with chemoradiotherapy in solid tumors: a systematic review and Meta-analysis[J]. China Oncology, 2025, 35(12): 1126-1139. DOI: 10.19401/j.cnki.1007-3639.2025.12.005.
Risk of cancer therapy-related cardiotoxicity following the use of PD-1/PD-L1 inhibitors combined with chemoradiotherapy compared with chemoradiotherapy in solid tumors: a systematic review and Meta-analysis
Microwave ablation versus hepatic resection in potentially resectable colorectal liver metastasis: a systematic review and meta-analysis
Survival impact of corticosteroid and immunosuppressant management strategies for immune-related adverse events in immune checkpoint inhibitor-treated patients: a systematic review and meta-analysis
A meta-analysis of the efficacy of 99Tc-MDP alone and in combination with 89SrCl2 in the treatment of bone metastases
The toxicity of chimeric antigen receptor T-cell immunotherapy in B-cell lymphoma: a Meta-analysis
Prognostic significance of platelet-to-lymphocyte ratio in patients with nasopharyngeal carcinoma: a Meta-analysis
Related Author
Guiying WANG
Jianfeng ZHANG
Longfei CAO
Baokun LI
Zesong MENG
Dongqin CHEN
Yicheng ZHOU
Xinyue LAN
Related Institution
The Second Department of General Surgery, The Fourth Hospital of Hebei Medical University
Department of General Surgery, The Second Hospital of Hebei Medical University
Department of Medical Oncology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine
National Medical Products Administration Key Laboratory for Clinical Research and Evaluation of Innovative Drugs, Institute of Clinical Trials, West China Hospital, Sichuan University
Department of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences